(Sharecast News) - Healthcare-focused advisory group Cello Health has sold its social media analytics software business, Pulsar, to Access Intelligence for £4.5m in shares.
The AIM-listed company said on Wednesday that the disposal will allow it to focus its capital investment on the higher growth and higher margin healthcare business as well as supporting the development of the core Signal business.
The consideration will be satisfied through the issue of just over 8.6m ordinary shares of 5 pence each and a £1 cash payment. Following the acquisition, Cello will own around 11.3% of Access Intelligence.
Cello chief executive Mark Scott said: "We are delighted that Pulsar can now begin the next stage in its development as a business whilst enabling Cello to focus on its core healthcare activities. We look forward to the ongoing partnership with Access Intelligence, both as a shareholder and as an ongoing user of Pulsar."
16 Sep 2015 10:06
Cello shares off key as pre-tax profits halved
(ShareCast News) - Shares in healthcare marketing company Cello Group plunged as interim pre-tax profits halved on the back of an ongoing tax dispute with the UK government and an expansion of its US activities. Pre-tax profits at the media advisory firm slumped to £1.7m in the six months to 30 June
Read more